Atlas Trials

Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor

Clinical trial NCT03259542 · COMPLETED

Trial details

NCT number
NCT03259542
Sponsor
Corcept Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug Interaction PotentiationHealthy
Start date
2017-08-09
Primary completion
2017-12-11
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.